New monocyte locomotion inhibitory factor analogs protect against cerebral ischemia-reperfusion injury in rats

New monocyte locomotion inhibitory factor analogs protect against cerebral ischemia-reperfusion injury in rats

Monocyte locomotion inhibitory factor (MLIF) is an oligopeptide with anti-inflammatory properties. The carboxyl-terminal end group Cys-Asn-Ser serves as the pharmacophore of MLIF. The aim of this study was to investigate the neuroprotective effects of two new synthetic analogs, Arg-Cys-Asn-Ser and D...

Full description

Bibliographic Details
Main Authors: Xiaoping Wang, Chao Wang, Yan Yang, Jingman Ni
Format: Article
Language:English
Published: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2017-08-01
Series:Bosnian Journal of Basic Medical Sciences
Subjects:
Monocyte locomotion inhibitory factor
inflammatory response
neuroprotection
cerebral ischemia/reperfusion
middle cerebral artery occlusion
rat model
Online Access:http://bjbms.org/ojs/index.php/bjbms/article/view/1622

Internet

http://bjbms.org/ojs/index.php/bjbms/article/view/1622

Similar Items